Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Research Reports

DNA Microarray Market To Reach USD 8,677.7 Million By 2028 – Reports and Data

Advancements in DNA microarray techniques, growing prevalence of various diseases, and increasing need for rapid and accurate diagnosis are key factors fueling global market growth The global DNA microarray market size is expected to reach USD 8677.7 Million by 2028 and register a CAGR of 12.6%, according to the latest report by Reports and Data. Rising prevalence of…

The post DNA Microarray Market To Reach USD 8,677.7 Million By 2028 – Reports and Data first appeared on News Degree | Hub for Latest and Trending News from Around the Globe.

Published : , on

Advancements in DNA microarray techniques, growing prevalence of various diseases, and increasing need for rapid and accurate diagnosis are key factors fueling global market growth

The global DNA microarray market size is expected to reach USD 8677.7 Million by 2028 and register a CAGR of 12.6%, according to the latest report by Reports and Data. Rising prevalence of cancer, growing adoption of DNA microarray technology in various applications such as cancer research, genetic disease diagnosis, and personalized medicine are key factors driving global market revenue growth.

DNA microarray is a laboratory tool used for measuring patterns of several genes simultaneously. It is a collection of microscopic DNA spots that are attached to a solid surface that aid in measuring expression of large number of genes at once. These microarrays are extensively used in gene expression, early-stage cancer detection, and drug discovery. The DNA microarray market is gaining significant traction in recent years. Increasing applications of DNA microarray technique, rapid growth in genomics and medical sector, rising prevalence of several chronic diseases and growing adoption of microarray techniques to detect various infectious diseases is boosting demand for DNA microarray across the world. Factors such as growing adoption of genetic testing, rising research and development activities in pharmaceutical and biotechnology sector, and rapid developments in healthcare infrastructure and facilities are boosting market growth. Moreover, increasing investments by leading players to develop more efficient and enhanced DNA microarrays is expected to boost growth of the global DNA microarray market during the forecast period. In addition, growing focus on R&D in cancer is projected to open lucrative opportunities for key players going ahead.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/288

However, high costs associated with sequencing and lack of skilled professionals to carry out these processes are expected to hamper global market revenue growth throughout the forecast period.

Some Key Highlights from the Report:

  • The Oligonucleotide DNA Microarrays (oDNA) segment is expected to register highest revenue CAGR throughout the forecast period. The oDNA microarrays are preferred over cDNA as they offer more hybridization specificity and are thus used for analyzing gene expression and single nucleotide polymorphisms.
  • Among the application segment, the drug discovery segment is projected to account for fastest revenue growth over the forecast period, owing to increasing prevalence of infectious diseases, cancer, and growing demand for DNA microarrays in drug discovery processes including disease pathway identification, compound screening, and clinical trials.
  • The academic & research institutes segment is projected to account for significant revenue growth during the forecast period owing to extensive use of DNA microarray in ongoing research and development activities and government funds for various research projects.
  • North America is expected to account for largest revenue share in the global DNA microarray market over the forecast period. Technological advancements in genomics, high prevalence of age-related chronic diseases, and access to modern research facilities are key factors contributing to global market revenue growth. In addition, high investments in research and development activities and presence of key players are fueling market growth.
  • The market in Asia Pacific is expected to register fastest revenue throughout the forecast period. Increasing investments in genomic research, high prevalence of diseases, and rising awareness about genetic testing are boosting market revenue growth.
  • Illumina, Affymetrix, Biometrix Technology, Arrayit, Sengenics, WaferGen, Applied Microarrays, Savyon Diagnostics, Scienion AG, Gyros AB, Agilent Technologies, Roche NimbleGen Inc., ProteoGenix, NextGen Sciences, Discerna, and Luminex Corporation are some leading companies operating in the global DNA array market.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/288

For this study, Reports and Data has segmented the global DNA microarray market based on type, application, end-use, and region:

Type Outlook (Revenue in USD Million, 2018–2028)

  • Complementary DNA Microarrays (cDNA)
  • Oligonucleotide DNA Microarrays (oDNA)

Application Outlook (Revenue in USD Million, 2018–2028)

  • Gene Expression Analysis
  • Genotyping
  • Genome Cytogenetics
  • Drug Delivery
  • Other

End-Use Outlook (Revenue, USD Million, 2018 – 2028)

  • Diagnostic Centers
  • Hospitals & Clinics
  • Biotechnology & Pharmaceutical Industries
  • Academic & Research Institutes
  • Others

Regional Outlook (Revenue, USD Million, 2018 – 2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Rest Of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/288

Key Questions Answered by the Report:

  • What are the key growth driving and restraining factors of the DNA Microarray market?
  • What are key opportunities and growth prospects of the DNA Microarray industry is expected to witness over the forecast period?
  • Who are the prominent players operating in the market? What are the key strategies adopted by these companies?
  • Which region is expected to dominate the market growth over the forecast period?
  • Which segments are expected to register lucrative growth over the forecast period?
  • What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis?

Thank you for reading our report. Please connect with us to know more about the report or for requesting customization of the report. Our team will ensure the report is best suited to meet your requirements.

Explore Reports and Data’s Prime Analysis of the global Healthcare & Pharmaceutical Industry:

Aesthetic Medicine Market   Trends, Share & Size, By Product Type (Energy-Based Devices, Implants, Anti-Wrinkle Products), By Application (Surgical, Non-Surgical), By End-Use (Medical Spas & Beauty Centers, Hospitals & Clinics, Home Use), By Region Forecast To 2027

Injectable Drug Delivery Market   Size, Share & Analysis, By Type (Formulation, Devices), By End-User (Hospital, Home Care, Ambulatory Care, Physician Offices or Clinics, Others), By Application (Autoimmune Diseases, Oncology Disorders, Others), By Region Forecast To 2027

Surgical Glue Market   Size, Share & Analysis, By Product (Natural, Synthetic), By Indication (Hemostasis, Tissue Sealing), By Application (Cardiac Surgery, Pulmonary Surgery, Vascular Surgery, Liver & Spleen Lacerations, Orthopedic Surgery, Burn Bleeding, Plastic Surgery, Wound Management, Neurosurgery, General Surgery, Others), By End-Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others), By Region, Forecast To 2027

Antidiabetics Market   Size, Trends & Analysis, By Patient Type (Pediatric, Adult, Geriatric), By Application (Type I Diabetes And Type II Diabetes), By Product (Insulin, Drug class), By Administration Mode (Insulin Syringe/Insulin Pen, Insulin Pump, Intravenous Infusion, Oral), By Region, Forecast To 2027

Hernia Mesh Market   By Hernia Type (Inguinal Hernia, Incisional Hernia, Femoral Hernia, and Others), By Mesh Type, By Synthetic Structure Type, By Synthetic Product Type, and By End Users And Segment Forecasts, 2016-2026

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]

Read Full Press Release: https://www.reportsanddata.com/press-release/global-dna-microarray-market

The post DNA Microarray Market To Reach USD 8,677.7 Million By 2028 – Reports and Data first appeared on News Degree | Hub for Latest and Trending News from Around the Globe.

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post